Highlights the high risk of central nervous system relapse in primary cardiac lymphoma and emphasizes the potential need for CNS screening and prophylaxis.
Answers are grounded in this paper and cite their sources.
Suggests a potential role for routine CNS screening in primary cardiac lymphoma; leaves open whether prophylactic therapy.
Primary cardiac lymphoma (PCL), a rare disease, often presents with symptoms resembling other cardiac diseases. The correct diagnosis is crucial, as cardiac lymphoma can be cured with immuno-chemotherapy. PCL has a high risk of central nervous system recurrence (CNS); therefore, screening for CNS involvement and even prophylaxis may be necessary.
No takes yet. Share an insight, caveat, or question.
Rooijen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: